Dr. Michael Armstrong Jr., MD

Dr. Armstrong practices at Stony Point Surgery Center, LLC - HOPD in Richmond, Virginia.

Dr. Armstrong's NPI, 1174608053, was assigned on October 26, 2006. Dr. Armstrong graduated from Duke University School of Medicine in 1989. Dr. Armstrong holds Virginia license 0101052066.

Dr. Armstrong's primary practice is Stony Point Surgery Center, LLC - HOPD, at 8700 Stony Point Parkway, Richmond, VA 23235.

Dr. Armstrong's primary practice is Stony Point Surgery Center, LLC - HOPD in Richmond, Virginia. Dr. Armstrong is also affiliated with VCU Medical Center. The medical group on file is Richmond ENT. Dmand AI also links Dr. Armstrong to 4 more hospitals, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Armstrong practices, 8 sites in all. Vendor and product names are available with a free account.

Otolaryngology/facial plastic surgery is Dr. Armstrong's primary specialty in the NPI Registry, under taxonomy code 207YX0905X. Dr. Armstrong is licensed in Virginia.

CMS data shows 2,922 Medicare services from Dr. Armstrong across 20 procedure codes in 2024, for 854 Medicare patients. Medicare paid $154,285 for them. Every service was in an office.

CMS counts 854 Medicare patients who saw Dr. Armstrong in 2024. The largest group is 65 to 74, with 409 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Armstrong's median patient age at 51, with 56% women.

In 2024, Dr. Armstrong wrote 92 Medicare Part D claims for 46 patients. 95% of them were for generic drugs. CMS names the drug for 28 of them, across 2 drugs with 11 or more claims each, at $529 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Armstrong for performance year 2024, reported as part of a group. Dr. Armstrong accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Armstrong to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Rhinitis and Nose Diseases. Neurent Medical sponsors the most, 2. Open Payments lists research payments to Dr. Armstrong that name 3 trials.

CMS Open Payments shows 242 general payments to Dr. Armstrong from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. Genentech, Inc. paid the most, $6,261. It also lists 18 research payments totaling $48,330 from 2023 to 2025, naming 3 clinical trials.

Dr. Armstrong graduated from Duke University School of Medicine in 1989.